Cargando…
The future is now: beyond first line systemic therapy in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is becoming a worldwide concern due to its rising incidence. Although for the incipient stages there are curative therapies, the advanced disease represents a major provocation for the clinicians. 2008 marked as an important year for the hepatology community with the a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797356/ https://www.ncbi.nlm.nih.gov/pubmed/35117106 http://dx.doi.org/10.21037/tcr.2018.11.23 |